medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 5

<< Back Next >>

Rev Invest Clin 2007; 59 (5)

Characterization of Naegleria fowleri strains isolated from human cases of primary amoebic meningoencephalitis in Mexico

Cervantes-Sandoval I, Serrano-Luna JJ, Tapia-Malagón JL, Pacheco-Yépez J, Silva-Olivares A, Galindo-Gómez S, Tsutsumi V, Shibayama M
Full text How to cite this article

Language: English
References: 8
Page: 342-347
PDF size: 165.69 Kb.


Key words:

Free-living amoebae, Naegleria fowleri, Primary amoebic meningoencephalitis, Case reports, Diagnosis.

ABSTRACT

The protozoon Naegleria fowleri (N. fowleri) is a free-living amoeba that produces primary amoebic meningoencephalitis (PAM), which is an acute and frequently fatal infection of the central nervous system. We characterized the strains of N. fowleri isolated from the cerebrospinal fluid (CSF) of two cases presented in northwestern Mexico. The strains were isolated and cultured in 2% bactocasitone medium. Enflagellation assays, ultrastructural analysis, protein and protease electrophoresis patterns, and PCR were performed as confirmatory tests. Virulence tests were done using in Balb/c mice. Light microscopy analysis of brain tissue showed amoebae with abundant inflammatory reaction and extensive necrotic and hemorrhagic areas. The enflagellation assay was positive and the electron microscopy showed trophozoites with morphologic features typical of the genus. Protein and protease profiles of the isolated strains were identical to the reference strain. Finally, a 1500-bp PCR product was found in all three strains. Based on all the analyses performed, we concluded that the etiologic agent of both PAM cases was N. fowleri. The need for better epidemiological information and educational programs about basic clinical and pathological aspects of free-living amoebae provided by the health authorities are emphasized.


REFERENCES

  1. Schuster FL, Visvesvara GS. Free-living amoeba as opportunistic and non-opportunistic pathogens of humans and animals. Int J Parasitol 2004; 34: 1001-27.

  2. Jarolim KL, McCosh JK, Howard MJ, John DT. A light microscopy study of the migration of N. fowleri from the nasal submucosa to the central nervous system during the early stage of primary amebic meningoencephalitis in mice. J Parasitol 2000; 86: 50-5.

  3. Lares-Villa F, De Jonkheere JF, De Moura H, Rechi-Iruretagoyena A, Ferreira-Guerrero E, Fernández-Quintanilla G, Ruíz-Matus C, Visvesvara GS. Five cases of primary amoebic meningoencephalitis in Mexicali, Mexico: study of the isolates. J Clin Microbiol 1993; 31: 685-8.

  4. Lares-Villa F. Free-living amoebae infections in Mexico. In: Proceedings of the IXth International Meeting on the Biology and Pathogenicity of Free-Living Amoebae, Paris, France, 8-14 July 2001 (Billot-Bonef S, Cabanes PA, Marciano-Cabral F, Pernin P, Pringuez E. Ed.) John Libbey Eurotext, 2001, pp. 13-8.

  5. Vargas-Zepeda J, Gómez-Alcala AV, Vásquez-Morales JA, Licea- Amaya L, De Jonckheere JF, Lares-Villa F. Successful treatment of Naegleria fowleri meningoencephalitis by using intravenous amphotericin B, fluconazole and rifampicin. Arch Med Res 2005; 36: 83-6.

  6. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54

  7. Kilvington S, Beeching J. Identification and epidemiological typing of Naegleria fowleri with DNA probes. Appl Environ Microbiol 1995; 61: 2071-8.

  8. Kilvington S, Beeching J. Development of a PCR for identification of Naegleria fowleri from the environment. Appl Environ Microbiol 1995; 61: 3764-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2007;59